Skip to main content
S 3353 116th Congress Senate

Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020

Official title: A bill to amend title XVIII of the Social Security Act to provide for extended months of Medicare coverage of immunosuppressive drugs for kidney transplant patients, and for other purposes.

Introduced: February 27, 2020 Introduced by: Cassidy, Bill Republican · Louisiana See on congress.gov
Health Congressional oversightDigestive and metabolic diseasesDrug therapyGovernment studies and investigations
More subjectsShow fewer subjects
Health care coverage and accessHealth promotion and preventive careMedicareOrgan and tissue donation and transplantationPrescription drugs
Sign in to write a letter Sign in to watch
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 27, 2020
Read twice and referred to the Committee on Finance.
Feb 27, 2020
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action February 27, 2020

Read twice and referred to the Committee on Finance.

 Plain-English summary Congressional Research Service

Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020

This bill indefinitely extends Medicare coverage of immunosuppressive drugs for kidney transplant recipients for individuals who do not have other coverage. Under current law, Medicare coverage is limited to 36 months following a transplant.

Additionally, the Government Accountability Office must report on the bill's implementation, including any related program integrity issues.

 Related & companion bills 1
  • HR 2477 Related bill Beneficiary Enrollment Notification and Eligibility Simplification Act of 2020
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 15
All 15 Democratic 6 Republican 9
R
Cornyn, John
Texas · Dec 17, 2020
 D
Smith, Tina
Minnesota · Oct 20, 2020
 R
Daines, Steve
Montana · Sep 30, 2020
 R
Cotton, Tom
Arkansas · Sep 16, 2020
 D
Gillibrand, Kirsten E.
New York · Sep 16, 2020
 R
Lankford, James
Oklahoma · Sep 16, 2020
 R
Boozman, John
Arkansas · Jul 30, 2020
 R
Scott, Rick
Florida · Jul 30, 2020
 D
Van Hollen, Chris
Maryland · Jul 30, 2020
 R
Capito, Shelley Moore
West Virginia · Jul 1, 2020
 D
Durbin, Richard J.
Illinois · Feb 27, 2020
 R
Ernst, Joni
Iowa · Feb 27, 2020
 D
Shaheen, Jeanne
New Hampshire · Feb 27, 2020
 D
Whitehouse, Sheldon
Rhode Island · Feb 27, 2020
 R
Young, Todd
Indiana · Feb 27, 2020
Cite this page click to expand
APA
U.S. Congress. (2026). S. 3353: Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020. 116th Congress. Open America. https://openamerica.io/bill/116-S-3353/
MLA
"S. 3353: Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-S-3353/.
Bluebook (legal)
S. 3353, 116th Cong. (2026), https://openamerica.io/bill/116-S-3353/.
Markdown link
[S. 3353: Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020](https://openamerica.io/bill/116-S-3353/)
Report a problem